Report Detail

Pharmaceuticals & Healthcare Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H2 2018

  • RnM2265861
  • |
  • 19 July, 2018
  • |
  • Global
  • |
  • 130 pages
  • |
  • Global Markets Direct
  • |
  • Pharmaceuticals & Healthcare

Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H2 2018

Table of Contents

    List of Tables

      List of Figures

        Introduction

          Global Markets Direct Report Coverage

            Acute Renal Failure (ARF) (Acute Kidney Injury) - Overview

              Acute Renal Failure (ARF) (Acute Kidney Injury) - Therapeutics Development

                Pipeline Overview

                  Pipeline by Companies

                    Pipeline by Universities/Institutes

                      Products under Development by Companies

                        Products under Development by Universities/Institutes

                          Acute Renal Failure (ARF) (Acute Kidney Injury) - Therapeutics Assessment

                            Assessment by Target

                              Assessment by Mechanism of Action

                                Assessment by Route of Administration

                                  Assessment by Molecule Type

                                    Acute Renal Failure (ARF) (Acute Kidney Injury) - Companies Involved in Therapeutics Development

                                      A1M Pharma AB

                                        Alloksys Life Sciences BV

                                          Am-Pharma BV

                                            Angion Biomedica Corp

                                              Arch Biopartners Inc

                                                Atox Bio Ltd

                                                  Balmes Transplantation SAS

                                                    Cellmid Ltd

                                                      CFM Pharma Holding BV

                                                        Cypralis Ltd

                                                          DURECT Corp

                                                            Evotec AG

                                                              Exponential Biotherapies Inc

                                                                F. Hoffmann-La Roche Ltd

                                                                  GeneScience Pharmaceuticals Co Ltd

                                                                    Klotho Therapeutics Inc

                                                                      Kringle Pharma Inc

                                                                        Mitobridge Inc

                                                                          Mitotech SA

                                                                            Quark Pharmaceuticals Inc

                                                                              SBI Pharmaceuticals Co Ltd

                                                                                Silver Creek Pharmaceuticals Inc

                                                                                  Spherium Biomed SL

                                                                                    STATegics Inc

                                                                                      Torrent Pharmaceuticals Ltd

                                                                                        Xigen SA

                                                                                          Acute Renal Failure (ARF) (Acute Kidney Injury) - Drug Profiles

                                                                                            (aminolevulinic acid hydrochloride + sodium ferrous citrate) - Drug Profile

                                                                                              Product Description

                                                                                                Mechanism Of Action

                                                                                                  R&D Progress

                                                                                                    ANG-4102 - Drug Profile

                                                                                                      Product Description

                                                                                                        Mechanism Of Action

                                                                                                          R&D Progress

                                                                                                            BB-3 - Drug Profile

                                                                                                              Product Description

                                                                                                                Mechanism Of Action

                                                                                                                  R&D Progress

                                                                                                                    brimapitide - Drug Profile

                                                                                                                      Product Description

                                                                                                                        Mechanism Of Action

                                                                                                                          R&D Progress

                                                                                                                            BT-0302 - Drug Profile

                                                                                                                              Product Description

                                                                                                                                Mechanism Of Action

                                                                                                                                  R&D Progress

                                                                                                                                    BT-0303 - Drug Profile

                                                                                                                                      Product Description

                                                                                                                                        Mechanism Of Action

                                                                                                                                          R&D Progress

                                                                                                                                            BT-0401 - Drug Profile

                                                                                                                                              Product Description

                                                                                                                                                Mechanism Of Action

                                                                                                                                                  R&D Progress

                                                                                                                                                    CAB-101 - Drug Profile

                                                                                                                                                      Product Description

                                                                                                                                                        Mechanism Of Action

                                                                                                                                                          R&D Progress

                                                                                                                                                            CC-4066 - Drug Profile

                                                                                                                                                              Product Description

                                                                                                                                                                Mechanism Of Action

                                                                                                                                                                  R&D Progress

                                                                                                                                                                    cerium oxide - Drug Profile

                                                                                                                                                                      Product Description

                                                                                                                                                                        Mechanism Of Action

                                                                                                                                                                          R&D Progress

                                                                                                                                                                            cilastatin - Drug Profile

                                                                                                                                                                              Product Description

                                                                                                                                                                                Mechanism Of Action

                                                                                                                                                                                  R&D Progress

                                                                                                                                                                                    Drug for Kidney Diseases - Drug Profile

                                                                                                                                                                                      Product Description

                                                                                                                                                                                        Mechanism Of Action

                                                                                                                                                                                          R&D Progress

                                                                                                                                                                                            DUR-928 - Drug Profile

                                                                                                                                                                                              Product Description

                                                                                                                                                                                                Mechanism Of Action

                                                                                                                                                                                                  R&D Progress

                                                                                                                                                                                                    EA-230 - Drug Profile

                                                                                                                                                                                                      Product Description

                                                                                                                                                                                                        Mechanism Of Action

                                                                                                                                                                                                          R&D Progress

                                                                                                                                                                                                            IL-233 - Drug Profile

                                                                                                                                                                                                              Product Description

                                                                                                                                                                                                                Mechanism Of Action

                                                                                                                                                                                                                  R&D Progress

                                                                                                                                                                                                                    iron sucrose + Sn protoporphyrin - Drug Profile

                                                                                                                                                                                                                      Product Description

                                                                                                                                                                                                                        Mechanism Of Action

                                                                                                                                                                                                                          R&D Progress

                                                                                                                                                                                                                            K-1052 - Drug Profile

                                                                                                                                                                                                                              Product Description

                                                                                                                                                                                                                                Mechanism Of Action

                                                                                                                                                                                                                                  R&D Progress

                                                                                                                                                                                                                                    KP-100IT - Drug Profile

                                                                                                                                                                                                                                      Product Description

                                                                                                                                                                                                                                        Mechanism Of Action

                                                                                                                                                                                                                                          R&D Progress

                                                                                                                                                                                                                                            MA-0204 - Drug Profile

                                                                                                                                                                                                                                              Product Description

                                                                                                                                                                                                                                                Mechanism Of Action

                                                                                                                                                                                                                                                  R&D Progress

                                                                                                                                                                                                                                                    Metablok - Drug Profile

                                                                                                                                                                                                                                                      Product Description

                                                                                                                                                                                                                                                        Mechanism Of Action

                                                                                                                                                                                                                                                          R&D Progress

                                                                                                                                                                                                                                                            MG-53 - Drug Profile

                                                                                                                                                                                                                                                              Product Description

                                                                                                                                                                                                                                                                Mechanism Of Action

                                                                                                                                                                                                                                                                  R&D Progress

                                                                                                                                                                                                                                                                    MTB-2 - Drug Profile

                                                                                                                                                                                                                                                                      Product Description

                                                                                                                                                                                                                                                                        Mechanism Of Action

                                                                                                                                                                                                                                                                          R&D Progress

                                                                                                                                                                                                                                                                            Plastomitin - Drug Profile

                                                                                                                                                                                                                                                                              Product Description

                                                                                                                                                                                                                                                                                Mechanism Of Action

                                                                                                                                                                                                                                                                                  R&D Progress

                                                                                                                                                                                                                                                                                    QPI-1002 - Drug Profile

                                                                                                                                                                                                                                                                                      Product Description

                                                                                                                                                                                                                                                                                        Mechanism Of Action

                                                                                                                                                                                                                                                                                          R&D Progress

                                                                                                                                                                                                                                                                                            R-190 - Drug Profile

                                                                                                                                                                                                                                                                                              Product Description

                                                                                                                                                                                                                                                                                                Mechanism Of Action

                                                                                                                                                                                                                                                                                                  R&D Progress

                                                                                                                                                                                                                                                                                                    Recombinant Alkaline Phosphatase Enzyme Replacement for Acute Kidney Injury - Drug Profile

                                                                                                                                                                                                                                                                                                      Product Description

                                                                                                                                                                                                                                                                                                        Mechanism Of Action

                                                                                                                                                                                                                                                                                                          R&D Progress

                                                                                                                                                                                                                                                                                                            Recombinant Human Alkaline Phosphatase Replacement for Acute Renal Failure, Hypophosphatasia, Sepsis and Ulcerative Colitis - Drug Profile

                                                                                                                                                                                                                                                                                                              Product Description

                                                                                                                                                                                                                                                                                                                Mechanism Of Action

                                                                                                                                                                                                                                                                                                                  R&D Progress

                                                                                                                                                                                                                                                                                                                    Recombinant Klotho Replacement for Kidney Disease, Aging, Breast Cancer, Cognitive Impairment and Type 2 Diabetes - Drug Profile

                                                                                                                                                                                                                                                                                                                      Product Description

                                                                                                                                                                                                                                                                                                                        Mechanism Of Action

                                                                                                                                                                                                                                                                                                                          R&D Progress

                                                                                                                                                                                                                                                                                                                            Recombinant Peptides to Agonize renalase for Acute Pancreatitis, Acute Kidney Injury and Cisplatin Induced Kidney Injury - Drug Profile

                                                                                                                                                                                                                                                                                                                              Product Description

                                                                                                                                                                                                                                                                                                                                Mechanism Of Action

                                                                                                                                                                                                                                                                                                                                  R&D Progress

                                                                                                                                                                                                                                                                                                                                    Recombinant Protein for Acute Kidney Injury, Acute Radiation Syndrome, Inflammatory Bowel Disease, Ischemic Organ Injury and Sepsis - Drug Profile

                                                                                                                                                                                                                                                                                                                                      Product Description

                                                                                                                                                                                                                                                                                                                                        Mechanism Of Action

                                                                                                                                                                                                                                                                                                                                          R&D Progress

                                                                                                                                                                                                                                                                                                                                            Recombinant Protein to Agonize GHR for Growth Failure In Children With Kidney Disease - Drug Profile

                                                                                                                                                                                                                                                                                                                                              Product Description

                                                                                                                                                                                                                                                                                                                                                Mechanism Of Action

                                                                                                                                                                                                                                                                                                                                                  R&D Progress

                                                                                                                                                                                                                                                                                                                                                    reltecimod sodium - Drug Profile

                                                                                                                                                                                                                                                                                                                                                      Product Description

                                                                                                                                                                                                                                                                                                                                                        Mechanism Of Action

                                                                                                                                                                                                                                                                                                                                                          R&D Progress

                                                                                                                                                                                                                                                                                                                                                            RLS-003 - Drug Profile

                                                                                                                                                                                                                                                                                                                                                              Product Description

                                                                                                                                                                                                                                                                                                                                                                Mechanism Of Action

                                                                                                                                                                                                                                                                                                                                                                  R&D Progress

                                                                                                                                                                                                                                                                                                                                                                    RMC-035 - Drug Profile

                                                                                                                                                                                                                                                                                                                                                                      Product Description

                                                                                                                                                                                                                                                                                                                                                                        Mechanism Of Action

                                                                                                                                                                                                                                                                                                                                                                          R&D Progress

                                                                                                                                                                                                                                                                                                                                                                            SGF-1 - Drug Profile

                                                                                                                                                                                                                                                                                                                                                                              Product Description

                                                                                                                                                                                                                                                                                                                                                                                Mechanism Of Action

                                                                                                                                                                                                                                                                                                                                                                                  R&D Progress

                                                                                                                                                                                                                                                                                                                                                                                    Small Molecule to Inhibit HDAC for Acute Kidney Injury - Drug Profile

                                                                                                                                                                                                                                                                                                                                                                                      Product Description

                                                                                                                                                                                                                                                                                                                                                                                        Mechanism Of Action

                                                                                                                                                                                                                                                                                                                                                                                          R&D Progress

                                                                                                                                                                                                                                                                                                                                                                                            Small Molecule to Inhibit PADI4 for Acute Kidney Injury, Hepatic and Pancreatic Injuries - Drug Profile

                                                                                                                                                                                                                                                                                                                                                                                              Product Description

                                                                                                                                                                                                                                                                                                                                                                                                Mechanism Of Action

                                                                                                                                                                                                                                                                                                                                                                                                  R&D Progress

                                                                                                                                                                                                                                                                                                                                                                                                    Small Molecules to Inhibit GGT for Acute Renal Injury - Drug Profile

                                                                                                                                                                                                                                                                                                                                                                                                      Product Description

                                                                                                                                                                                                                                                                                                                                                                                                        Mechanism Of Action

                                                                                                                                                                                                                                                                                                                                                                                                          R&D Progress

                                                                                                                                                                                                                                                                                                                                                                                                            Stem Cell Therapy for Diabetic Foot Ulcers, Epidermolysis Bullosa, Liver Diseases, Kidney Disease, Peripheral Artery Occlusive Disease and Skin Ulcers - Drug Profile

                                                                                                                                                                                                                                                                                                                                                                                                              Product Description

                                                                                                                                                                                                                                                                                                                                                                                                                Mechanism Of Action

                                                                                                                                                                                                                                                                                                                                                                                                                  R&D Progress

                                                                                                                                                                                                                                                                                                                                                                                                                    STSE-15 - Drug Profile

                                                                                                                                                                                                                                                                                                                                                                                                                      Product Description

                                                                                                                                                                                                                                                                                                                                                                                                                        Mechanism Of Action

                                                                                                                                                                                                                                                                                                                                                                                                                          R&D Progress

                                                                                                                                                                                                                                                                                                                                                                                                                            SUL-138 - Drug Profile

                                                                                                                                                                                                                                                                                                                                                                                                                              Product Description

                                                                                                                                                                                                                                                                                                                                                                                                                                Mechanism Of Action

                                                                                                                                                                                                                                                                                                                                                                                                                                  R&D Progress

                                                                                                                                                                                                                                                                                                                                                                                                                                    TRC-160334 - Drug Profile

                                                                                                                                                                                                                                                                                                                                                                                                                                      Product Description

                                                                                                                                                                                                                                                                                                                                                                                                                                        Mechanism Of Action

                                                                                                                                                                                                                                                                                                                                                                                                                                          R&D Progress

                                                                                                                                                                                                                                                                                                                                                                                                                                            Vanadis-03 - Drug Profile

                                                                                                                                                                                                                                                                                                                                                                                                                                              Product Description

                                                                                                                                                                                                                                                                                                                                                                                                                                                Mechanism Of Action

                                                                                                                                                                                                                                                                                                                                                                                                                                                  R&D Progress

                                                                                                                                                                                                                                                                                                                                                                                                                                                    Acute Renal Failure (ARF) (Acute Kidney Injury) - Dormant Projects

                                                                                                                                                                                                                                                                                                                                                                                                                                                      Acute Renal Failure (ARF) (Acute Kidney Injury) - Discontinued Products

                                                                                                                                                                                                                                                                                                                                                                                                                                                        Acute Renal Failure (ARF) (Acute Kidney Injury) - Product Development Milestones

                                                                                                                                                                                                                                                                                                                                                                                                                                                          Featured News & Press Releases

                                                                                                                                                                                                                                                                                                                                                                                                                                                            Jul 09, 2018: Quark Pharmaceuticals Announces First Patient Dosed in Phase 3 Clinical Trial of QPI-1002 for Prevention of Acute Kidney Injury Following Cardiac Surgery

                                                                                                                                                                                                                                                                                                                                                                                                                                                              May 29, 2018: Atox Bio Announces Enrollment of First Patient in Phase 2 Study of Acute Kidney Injury (AKI)

                                                                                                                                                                                                                                                                                                                                                                                                                                                                May 22, 2018: Arch Biopartners Engages Nucro-Technics To Complete Toxicology Studies To Support Investigational New Drug Application For Metablok

                                                                                                                                                                                                                                                                                                                                                                                                                                                                  May 08, 2018: Arch Biopartners Completes Pre-IND Meeting with U.S. FDA on LSALT Peptide for Preventing Acute Kidney Injury in Cardiac Surgery Patients

                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Mar 21, 2018: Arch Biopartners Granted Pre-Ind Meeting With FDA for Candidate Drug to Prevent Acute Kidney Injury

                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Mar 09, 2018: AM-Pharma announces Phase II study results of recAP in sepsis-associated Acute Kidney Injury

                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Feb 27, 2018: Arch Biopartners Announces Start of GMP Manufacturing for Metablok at CSBio

                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Nov 14, 2017: A1M Pharma reports positive results from its GLP toxicology study - now able to finalize application to initiate clinical studies

                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Nov 07, 2017: Quark Pharmaceuticals to Present Positive Phase 2 Efficacy And Safety Results Of QPI-1002, A siRNA Targeting p53, For Prevention Of Acute Kidney Injury Following Cardiac Surgery, at the EuroTIDES Conference

                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Nov 07, 2017: ROSgard protects bone marrow during radiation treatment - patent application has been filed

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                Nov 06, 2017: Mitobridge Presents Preclinical Data Demonstrating Beneficial Effects of PPARd Modulators in Acute Kidney Injury at American Society of Nephrology Annual Meeting

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Nov 04, 2017: Quark Pharmaceuticals Presents Results from a Positive Phase 2 Study of QPI-1002 for Prevention of Acute Kidney Injury Following Cardiac Surgery at the American Society of Nephrology Meeting

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Nov 01, 2017: Quark Pharmaceuticals Phase 2 Data on the Efficacy and Safety of QPI-1002 for Prevention of Acute Kidney Injury Following Cardiac Surgery to Be Presented at the American Society of Nephrology Meeting

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Oct 27, 2017: A1M Pharma: First company in the world with large scale manufacturing of A1M under full GMP compliance for clinical studies

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Sep 13, 2017: Patented the first drug that acts as a protector of the kidney

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Appendix

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Methodology

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Coverage

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                Secondary Research

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Primary Research

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Expert Panel Validation

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Contact Us

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Disclaimer

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H2 2018

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Summary

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H2 2018, provides an overview of the Acute Renal Failure (ARF) (Acute Kidney Injury) (Genito Urinary System And Sex Hormones) pipeline landscape.

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Acute kidney failure occurs when kidneys suddenly become unable to filter waste products from blood. Symptoms include drowsiness, shortness of breath, fatigue, seizures or coma in severe cases and chest pain. The predisposing factors include age, diabetes, high blood pressure, heart failure and kidney diseases. Treatment includes antibiotics and diuretics.

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Report Highlights

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Acute Renal Failure (ARF) (Acute Kidney Injury) (Genito Urinary System And Sex Hormones), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        The Acute Renal Failure (ARF) (Acute Kidney Injury) (Genito Urinary System And Sex Hormones) pipeline guide also reviews of key players involved in therapeutic development for Acute Renal Failure (ARF) (Acute Kidney Injury) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, Preclinical and Discovery stages are 3, 4, 5, 24 and 4 respectively. Similarly, the Universities portfolio in Preclinical stages comprises 3 molecules, respectively.

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Acute Renal Failure (ARF) (Acute Kidney Injury) (Genito Urinary System And Sex Hormones) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Scope

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        - The pipeline guide provides a snapshot of the global therapeutic landscape of Acute Renal Failure (ARF) (Acute Kidney Injury) (Genito Urinary System And Sex Hormones).
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        - The pipeline guide reviews pipeline therapeutics for Acute Renal Failure (ARF) (Acute Kidney Injury) (Genito Urinary System And Sex Hormones) by companies and universities/research institutes based on information derived from company and industry-specific sources.
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        - The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        - The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        - The pipeline guide reviews key companies involved in Acute Renal Failure (ARF) (Acute Kidney Injury) (Genito Urinary System And Sex Hormones) therapeutics and enlists all their major and minor projects.
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        - The pipeline guide evaluates Acute Renal Failure (ARF) (Acute Kidney Injury) (Genito Urinary System And Sex Hormones) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        - The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        - The pipeline guide reviews latest news related to pipeline therapeutics for Acute Renal Failure (ARF) (Acute Kidney Injury) (Genito Urinary System And Sex Hormones)

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Reasons to buy

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        - Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        - Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        - Find and recognize significant and varied types of therapeutics under development for Acute Renal Failure (ARF) (Acute Kidney Injury) (Genito Urinary System And Sex Hormones).
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        - Classify potential new clients or partners in the target demographic.
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        - Develop tactical initiatives by understanding the focus areas of leading companies.
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        - Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        - Formulate corrective measures for pipeline projects by understanding Acute Renal Failure (ARF) (Acute Kidney Injury) (Genito Urinary System And Sex Hormones) pipeline depth and focus of Indication therapeutics.
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        - Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.


                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Summary:
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Get latest Market Research Reports on Acute Renal Failure (ARF) (Acute Kidney Injury). Industry analysis & Market Report on Acute Renal Failure (ARF) (Acute Kidney Injury) is a syndicated market report, published as Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H2 2018. It is complete Research Study and Industry Analysis of Acute Renal Failure (ARF) (Acute Kidney Injury) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        REPORT YOU MIGHT BE INTERESTED

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Purchase this Report

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        $2,000.00
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        $4,000.00
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        $6,000.00
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        1,602.69
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        3,205.38
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        4,808.07
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        1,783.25
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        3,566.51
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        5,349.76
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        215,720.00
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        431,440.00
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        647,160.00
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        137,792.80
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        275,585.60
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        413,378.40
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Credit card Logo

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Related Reports


                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Reason to Buy

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Request for Sample of this report